Dark Forest Capital Management LP Uni Qure N.V. Transaction History

Dark Forest Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$16.98 - $25.54 $135 - $204	8 New	8 $0
Q1 2022 May 13, 2022	SELL	$14.54 - $21.5 $72 - $107	-5 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$20.24 - $36.01 $101 - $180	5 New	5 $0
Q3 2021 Nov 12, 2021	SELL	$26.01 - $38.22 $23,148 - $34,015	-890 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$29.97 - $37.17 $26,673 - $33,081	890 New	890 $27,000

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.